Loading...
XJPX4540
Market cap2.27bUSD
Dec 26, Last price  
4,711.00JPY
1D
0.77%
1Q
5.37%
Jan 2017
46.30%
Name

Tsumura & Co

Chart & Performance

D1W1MN
XJPX:4540 chart
P/E
21.41
P/S
2.37
EPS
220.02
Div Yield, %
1.43%
Shrs. gr., 5y
-0.12%
Rev. gr., 5y
4.52%
Revenues
150.85b
+7.71%
84,828,000,00090,425,000,00091,252,000,00094,804,000,00090,027,000,00090,933,000,00094,778,000,00095,451,000,000105,639,000,000110,057,000,000110,438,000,000112,618,000,000114,957,000,000117,882,000,000120,906,000,000123,248,000,000130,881,000,000129,546,000,000140,043,000,000150,845,000,000
Net income
16.71b
+1.37%
10,401,000,00012,380,000,00013,152,000,0009,139,000,00010,777,000,00010,704,000,00012,945,000,00013,431,000,00015,373,000,00018,050,000,00014,075,000,00012,557,000,00012,488,000,00014,504,000,00014,593,000,00013,765,000,00015,332,000,00018,836,000,00016,482,000,00016,707,000,000
CFO
5.61b
-65.91%
5,063,000,00014,593,000,00012,687,000,0005,358,000,00010,634,000,00012,019,000,00012,047,000,0007,314,000,00012,011,000,0005,908,000,0004,992,000,00017,570,000,00021,065,000,00021,066,000,0005,450,000,00018,191,000,00016,102,000,00021,314,000,00016,452,000,0005,608,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 04, 2025

Profile

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.
URL
https://www.tsumura.co.jp/
IPO date
Nov 21, 1980
Employees
4,032
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
150,845,000
7.71%
140,043,000
8.10%
129,546,000
-1.02%
Cost of revenue
90,316,000
79,356,000
70,394,000
Unusual Expense (Income)
NOPBT
60,529,000
60,687,000
59,152,000
NOPBT Margin
40.13%
43.33%
45.66%
Operating Taxes
5,689,000
5,632,000
6,167,000
Tax Rate
9.40%
9.28%
10.43%
NOPAT
54,840,000
55,055,000
52,985,000
Net income
16,707,000
1.37%
16,482,000
-12.50%
18,836,000
22.85%
Dividends
(5,126,000)
(4,896,000)
(4,896,000)
Dividend yield
1.76%
2.44%
2.00%
Proceeds from repurchase of equity
(1,316,000)
(30,303,000)
BB yield
0.45%
15.07%
Debt
Debt current
25,313,000
10,313,000
10,313,000
Long-term debt
54,985,000
69,639,000
39,609,000
Deferred revenue
5,000
170,000
55,000
Other long-term liabilities
7,386,000
6,625,000
6,099,000
Net debt
(13,018,000)
(33,385,000)
(36,162,000)
Cash flow
Cash from operating activities
5,608,000
16,452,000
21,314,000
CAPEX
(16,823,000)
(14,708,000)
(10,587,000)
Cash from investing activities
(19,351,000)
(15,493,000)
(9,111,000)
Cash from financing activities
(4,417,000)
24,423,000
(8,181,000)
FCF
17,743,000
41,365,000
38,320,000
Balance
Cash
78,075,000
94,752,000
67,552,000
Long term investments
15,241,000
18,585,000
18,532,000
Excess cash
85,773,750
106,334,850
79,606,700
Stockholders' equity
284,002,000
259,573,000
245,058,000
Invested Capital
296,969,250
228,962,150
212,735,300
ROIC
20.85%
24.93%
25.72%
ROCE
15.72%
17.01%
18.95%
EV
Common stock shares outstanding
76,002
76,437
76,507
Price
3,823.00
45.36%
2,630.00
-17.81%
3,200.00
-19.09%
Market cap
290,555,646
44.53%
201,029,310
-17.89%
244,822,400
-19.09%
EV
302,099,646
187,843,310
226,999,400
EBITDA
71,283,000
71,299,000
68,341,000
EV/EBITDA
4.24
2.63
3.32
Interest
330,000
256,000
173,000
Interest/NOPBT
0.55%
0.42%
0.29%